Targeted D4 Dopamine Receptors: Implications for Drug Discovery and Therapeutic Development

E-ISSN： 1873-5592|14|4|507-512

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.4, 2013-04, pp. : 507-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Absence of detectable striatal dopamine D 4 receptors in drug-treated schizophrenia

By Reynolds G.P. Mason S.L.

European Journal of Pharmacology, Vol. 281, Iss. 2, 1995-08 ,pp. : 5-6

Elsevier

Access to resources Recommend Favorite

The dopamine D 4 receptors and mechanisms of antipsychotic atypicality

By Wong A.H.C. Van Tol H.H.M.

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 7, 2003-10 ,pp. : 1091-1099

Elsevier

Access to resources Recommend Favorite

Biomarker Analysis as a Decision-Making Tool in Drug Discovery and Development: Implications for Peroxisome Proliferator-Activator Receptors

By Stoch S. Aubrey Wagner John A.

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 4, 2007-01 ,pp. : 271-277

Adis International

Access to resources Recommend Favorite

Dopamine D Receptors: Relevance for the Drug Treatment of Parkinson's Disease

By Levant B.

CNS Drugs, Vol. 12, Iss. 5, 1999-11 ,pp. : 391-402

Adis International

Access to resources Recommend Favorite

Dopamine and Depression: Therapeutic Implications

By Rampello L.

CNS Drugs, Vol. 13, Iss. 1, 2000-01 ,pp. : 35-45

Adis International

Access to resources Recommend Favorite